adalimumab intralesional
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for adalimumab intralesional, covering 2018-12-13 to 2018-12-13. Get the full timeline:
Most recent: Clinical Trial Update: Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients [Phase 3]